
doi: 10.1002/wsbm.1538
pmid: 35023325
AbstractTetracycline and its derivative tigecycline are clinical options against Gram‐negative bacterial infections. The emergence of mobile Tet(X) enzymes that destruct tetracycline‐type antibiotics is posing a big challenge to antibacterial therapy and food/environmental securities. Here, we present an update on a growing number of Tet(X) variants. We describe structure and action of Tet(X) enzyme, and discuss the evolutional origin. In addition, potential Tet(X) inhibitors are given. This mini‐review might benefit better understanding of Tet(X)‐mediated tigecycline resistance.This article is categorized under: Infectious Diseases > Genetics/Genomics/Epigenetics Infectious Diseases > Environmental Factors Infectious Diseases > Molecular and Cellular Physiology
Tetracycline Resistance, Microbial Sensitivity Tests, Tetracycline, Tigecycline, Anti-Bacterial Agents
Tetracycline Resistance, Microbial Sensitivity Tests, Tetracycline, Tigecycline, Anti-Bacterial Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
